MedCity News

NOVEMBER 14, 2023

Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.”

Leads 290

Leads Pharma Pharmaceutical Patients 290

MedCity News

APRIL 10, 2024

The lead indication for the Alpine drug, povetacicept, is the chronic kidney disease IgA nephropathy. The post Vertex Pharma Bolsters Immunology Profile With $4.9B Vertex Pharmaceuticals gains a Phase 3-ready Alpine Immune Sciences drug with potential applications in a wide range of immunological disorders.

Pharma 304

Pharma Pharmaceutical Leads Biopharma 304

MedCity News

OCTOBER 20, 2024

Pharmaceutical and biotech companies are using generative AI to predict drug-target interactions, optimize lead compounds, and generate novel molecular structures. The post How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come appeared first on MedCity News.

Pharma 331

Pharma Leads Pharmaceutical Biopharma 331

MedCity News

JANUARY 24, 2025

Ascentage Pharmas U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to develop and commercialize one of those drugs in most of the world. The post Ascentage Has First U.S.

Pharma 217

Pharma Leads Biopharma 217

Impetus Digital

DECEMBER 23, 2024

Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. Transform your approach and lead the curve in training!

Education 110

Education Medical Pharma Training 110

MedCity News

APRIL 30, 2024

Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer appeared first on MedCity News. With cancer as its initial focus, the startup contends its approach could offer safety and efficacy advantages compared to currently available targeted therapies. The post J.P.

Leads 321

Leads Safety Biopharma Pharma 321

MedCity News

MAY 6, 2024

Novo-Catalent Deal, Leading to Another Delay appeared first on MedCity News. Just weeks after Novo decided to resubmit its application to the FTC, the agency is seeking more information about the deal. This move has triggered a second 30-day delay in the antitrust review process. The post FTC Seeks More Information on the $16.5B

Leads 306

Leads Management Biopharma Pharma 306

MedCity News

NOVEMBER 27, 2022

The biotech’s Series D financing round lays the groundwork to bring its lead program into the clinic in mid-2023, as well as support development of the rest of its pipeline of peptide drugs. FogPharma is preclinical, but not for long.

Leads 299

Leads Biopharma Pharma 299

MedCity News

DECEMBER 5, 2023

Replimune’s lead therapeutic candidate did not meet the two main goals of a study intended to support an FDA submission in cutaneous squamous cell carcinoma. But Replimune’s therapy, an oncolytic virus, has better data in melanoma, and the company plans a 2024 FDA submission in this skin cancer.

Leads 299

Leads FDA Biopharma Pharma 299

MedCity News

JANUARY 19, 2023

Sun Pharmaceuticals is acquiring Concert Pharmaceuticals, a biotech whose lead program has positive data from two late-stage clinical trials in alopecia areata. The deal gives Sun Pharma a drug candidate that could match up against hair loss drugs from two big pharmaceutical companies.

Pharma 278

Pharma Pharmaceutical Leads Biopharma 278

World of DTC Marketing

JULY 9, 2021

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” We are reminded that big pharma is a business whose only purpose is to make money. Big pharma is big business. billion. .” That is reprehensible.

Pharma 292

Pharma FDA Leads Competition 292

World of DTC Marketing

MARCH 9, 2021

Pharma has an opportunity to engage customers and caregivers via email but they can’t send out product flyers. With email automation tools, you don’t have to miss another opportunity to generate leads, sales, and revenue again. The other challenge for pharma in an email marketing campaign is privacy.

Marketing 289

Marketing Pharma Prospecting Education 289

PharmaVoice

NOVEMBER 6, 2023

Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.

Ethics 246

Ethics Leads Pharma 246

MedCity News

DECEMBER 9, 2024

The data, presented Monday during the annual meeting of the American Society of Hematology, are part of a submission now under FDA review that could lead to Blenreps return to the market. The post GSK Multiple Myeloma Drugs DREAMM Comeback Continues With Phase 3 Data at ASH appeared first on MedCity News.

FDA 290

FDA Leads Marketing Patients 290

Fierce Pharma

MAY 7, 2024

With Hyrimoz leading the way, sales of the company’s biosimilars reached $623 million in the first three months of this year. . | After spinning off as a separate business from Novartis, Sandoz is riding the wave of a strong launch of its biosimilar version of AbbVie’s Humira (adalimumab).

Leads 247

Leads Sales 247

Fierce Pharma

OCTOBER 30, 2024

Sales of Eli Lilly’s diabetes and weight loss drugs fell far short of expectations in the third quarter, leading the juggernaut company to reduce its annual revenue guidance and triggering speculat | Sales of Eli Lilly’s diabetes and weight loss drugs fell far short of analyst expectations in the third quarter, leading the juggernaut company to reduce (..)

Sales 281

Sales Leads 281

MedCity News

OCTOBER 29, 2024

Crescent’s lead program is a bispecific antibody for cancer that replicates the properties of a Summit Therapeutics bispecific drug that recently trounced Merck’s blockbuster med Keytruda in a pivotal head-to-head study.

Biopharma 299

Biopharma Leads Pharma 299

Fierce Pharma

MARCH 14, 2023

Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US kdunleavy Tue, 03/14/2023 - 10:56

Leads 253

Leads 253

World of DTC Marketing

DECEMBER 29, 2020

Let’s also remember that pharma is going to make a LOT of money on these vaccines. Rather than have patients fill out the paperwork online and get a specific time for their shot, Florida uses the cattle car mentality, leading to people waiting overnight. The post How did pharma develop a vaccine so quickly?

Pharma 307

Pharma Food and Drug Administration Media Food 307

MedCity News

JANUARY 24, 2023

Clinical trial setbacks and financial challenges have led Finch Therapeutics to stop a Phase 3 study for its lead microbiome program, a potential treatment for recurrent C. diff infection. As Finch seeks buyers for its remaining assets, the biotech is laying off most of its staff in a corporate restructuring.

Leads 244

Leads Biopharma Pharma 244

Pharma Marketing Network

APRIL 2, 2025

Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes.

Marketing 64

Marketing Pharma Sales pitches Networking 64

MedCity News

MAY 2, 2024

Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big pharma M&A moves in the red-hot radiopharmaceuticals space.

Pharma 321

Pharma Leads Biopharma 321

PharmaVoice

AUGUST 17, 2023

The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.

Leads 246

Leads Pharma 246

World of DTC Marketing

AUGUST 12, 2022

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston. In my opinion, PhRMA has zero credibility.

Pharma 255

Pharma Retail Pharmaceutical Pharmaceutical manufacturing 255

Fierce Pharma

OCTOBER 29, 2024

Modified dosing regimen of Eli Lilly's Alzheimer's drug leads to significant reduction in brain swelling kdunleavy Tue, 10/29/2024 - 15:25

Leads 218

Leads 218

Fierce Pharma

MAY 9, 2024

While Vertex leads in patient starts, bluebird has activated more treatment centers. It’s not an easy question to answer.

Leads 236

Leads Patients FDA Pharmaceutical 236

PharmaVoice

SEPTEMBER 11, 2024

A broader approach recognizes the challenges disproportionately impacting women and could lead to better outcomes, according to Organon.

Pharma 246

Pharma Leads 246

PharmaVoice

JULY 20, 2023

Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.

Leads 246

Leads Pharma 246

Fierce Pharma

NOVEMBER 8, 2023

In the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly. | In the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly.

FDA 296

FDA Pharma Leads 296

Fierce Pharma

JANUARY 10, 2024

In AZ's push to reach industry-leading growth by 2030, confidence is key, chief financial officer Aradhana Sarin said at the J.P. With a late-stage pipeline spanning more than 120 clinical trials and a firm grasp of five major disease areas, AstraZeneca appears confident heading into 2024. | Morgan Healthcare Conference.

Leads 246

Leads Healthcare Healthcare 246

MedCity News

SEPTEMBER 12, 2023

The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder. Avalon BioVentures unveiled new portfolio company Arialys Therapeutics.

Pharma 311

Pharma Leads Biopharma 311

MedCity News

MAY 18, 2023

The company’s lead product candidate is in mid-stage development for wet age-related macular degeneration and non-proliferative diabetic retinopathy. By selling U.S. rights to Yutiq, EyePoint Pharmaceuticals gets $75 million cash to support its drug pipeline.

Pharma 298

Pharma Pharmaceutical Leads Biopharma 298

MedCity News

MARCH 4, 2024

Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance itself from a placebo measured at nearly two years of treatment. The latest Akero data build on six-month results reported in 2022.

Leads 312

Leads Biopharma Pharma 312

Pharma Marketing Network

MARCH 26, 2025

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? Key pillars include: 1.

Marketing 64

Marketing Pharma Government Training 64

Fierce Pharma

FEBRUARY 5, 2024

After Novartis reportedly backed out of late-stage talks to acquire Cytoki | The company has a leading bid for the cancer drug maker over Incyte, Reuters reports, citing two people familiar with the matter.

Leads 196

Leads 196

Pharma Marketing Network

MARCH 19, 2025

To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

Media 52

Media Marketing Pharma Ethics 52

MedCity News

JUNE 30, 2024

AbbVie has acquired Celsius Therapeutics, a startup whose lead program is in early clinical development for inflammatory bowel disease. It’s the latest in a series of AbbVie business deals that broaden the pharma company’s scope in the gastrointestinal condition.

Pharma 287

Pharma Leads Biopharma 287